Ted Love

(Dr. Ted Love M.D.)

Currently holds positions in Santarus Inc, Amicus Therapeutics Inc, Portola Pharmaceuticals Inc and Global Blood Therapeutics Inc

Positions

Position Company Period
Independent Director Santarus Inc March 18, 2005 -
Independent Director Amicus Therapeutics Inc June 13, 2012 -
Independent Director Portola Pharmaceuticals Inc Sept. 19, 2019 -
President, Chief Executive Officer, Director Global Blood Therapeutics Inc June 1, 2014 -
Independent Director Cascadian Therapeutics Inc Sept. 5, 2013 - March 9, 2018
Lead Independent Director Humanigen Inc May 28, 2015 - Nov. 19, 2015
Independent Chairman of the Board Humanigen Inc May 1, 2014 - May 28, 2015
Independent Director Humanigen Inc March 1, 2009 - May 1, 2014
Independent Director Savara Inc Sept. 5, 2012 - Aug. 7, 2013
Independent Director Bio Rad Laboratories Inc March 24, 2010 - April 23, 2013
Executive Vice President, Head - Research and Development and Technical Operations Onyx Pharmaceuticals Inc Jan. 1, 2011 - Aug. 1, 2012
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2020-04-29 2020-04-28 PS Planned sale
40,000 -3.7%
80.00
USD 3,200,160
40,000 -3.7% 80.00 USD 3,200,160
2020-04-29 2020-04-27 PS Planned sale
1,517 -0.1%
80.63
USD 122,320
1,517 -0.1% 80.63 USD 122,320
2020-04-29 2020-04-27 PS Planned sale
1,300 -0.1%
81.15
USD 105,494
1,300 -0.1% 81.15 USD 105,494
2020-02-20 2020-02-18 PS Planned sale
1,818 -0.2%
70.92
USD 128,940
1,818 -0.2% 70.92 USD 128,940
2020-02-20 2020-02-18 PS Planned sale
2,189 -0.2%
70.22
USD 153,721
2,189 -0.2% 70.22 USD 153,721
2020-01-23 2020-01-22 PS Planned sale
1,031 -0.1%
82.45
USD 85,011
1,031 -0.1% 82.45 USD 85,011
2020-01-23 2020-01-22 PS Planned sale
32,150 -2.9%
81.85
USD 2,631,600
32,150 -2.9% 81.85 USD 2,631,600
2020-01-23 2020-01-22 PS Planned sale
6,819 -0.6%
81.01
USD 552,436
6,819 -0.6% 81.01 USD 552,436
2020-01-23 2020-01-21 PS Planned sale
523 -0.0%
83.56
USD 43,703
523 -0.0% 83.56 USD 43,703
2020-01-23 2020-01-21 PS Planned sale
10,166 -0.9%
82.78
USD 841,562
10,166 -0.9% 82.78 USD 841,562
2020-01-23 2020-01-21 PS Planned sale
29,311 -2.6%
81.98
USD 2,402,837
29,311 -2.6% 81.98 USD 2,402,837
// ... existing code ... // ... rest of the file ...